Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

The Goldman Sachs Group Issues Positive Forecast for Moderna (NASDAQ:MRNA) Stock Price

Summary by MarketBeat
The Goldman Sachs Group raised their target price on shares of Moderna from $137.00 to $195.00 and gave the stock a "neutral" rating in a report on Monday.

2 Articles

MarketBeatMarketBeat
Center

The Goldman Sachs Group Issues Positive Forecast for Moderna (NASDAQ:MRNA) Stock Price

The Goldman Sachs Group raised their target price on shares of Moderna from $137.00 to $195.00 and gave the stock a "neutral" rating in a report on Monday.

·Sioux Falls, United States
Read Full Article
BITRSSBITRSS

MRNA Price Prediction: Moderna tests resistance as earnings strength clashes with heavy short bias

Moderna Tokenized Stock (MRNA) is trading at $259.31, just below its immediate resistance band and above all listed short-term moving averages. On Binance Futures, momentum is constructive but posi... (Read More)

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

BITRSS broke the news on Monday, November 9, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Moderna icon

Moderna

Stock Markets icon

Stock Markets

New York City icon

New York City

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal